Allstripes Announces $50 Million Series B Financing To Advance Global Rare Disease Research
PRIVATEAug 24, 2021
Amount Raised
$50 Million
Round Type
Series B
San FranciscoHealth Care
Description
AllStripes (“Company”), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B financing round.
Who else raised in Health Care around the same time
Companies in the same sectors as All Stripes that raised within 45 days of this round, from Fundz verified event records.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
All Stripes
Location
San Francisco, California, United States
About
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors. For more information, visit www.allstripes.com.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment All Stripes raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.